Aman Sohal

Aman Sohal is an experienced Business Analyst with a strong background in clinical trial management systems (CTMS) and regulatory compliance. Currently employed at Biogen since January 2021, Aman has been instrumental in configuring the CTMS platform, conducting user acceptance testing, and developing robust data management protocols. Prior experience includes roles at Amgen, where collaborative efforts with cross-functional teams enhanced CTMS alignment, and Alnylam Pharmaceuticals, where adherence to 21CFR guidelines was enforced. Additionally, Aman contributed to quality management systems at Bristol Myers Squibb, ensuring compliance with Good Manufacturing Practices and regulatory guidelines. Aman holds a degree from Lovely Professional University.